Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1.

Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1. Cell Rep. 2015 Mar 24; 10(11):1850-60.

View in: PubMed